Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer

NCT04845503 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT04845503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04845503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer
Lead sponsor
University Hospital Heidelberg
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 25, 2021
Completion date
March 25, 2028
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer